Search results for "Randomized controlled"

showing 10 items of 2220 documents

Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol

2006

Objectives: to evaluate the clinical efficacy and the effects on the quality of life of Iloprost, a prostacyclin analogue, used, according to a new protocol, in patients with Raynaud’s phenomenon secondary to Systemic Sclerosis. Methods: in this randomized study we treated 30 patients with Iloprost given by intravenous infusion, at progressively increasing doses (starting from 0.5 ng/Kg/min up 2 ng/Kg/min) over a period of 6 hours a day for ten days in two consecutive weeks, with repeated cycles at regular intervals of three months for 18 months. The results were compared with those obtained in 30 other patients, who had received the same drug but with different posologic schemes. Results: …

AdultMalemedicine.medical_specialtyTime FactorsVasodilator AgentsSeverity of Illness IndexDrug Administration ScheduleSclerodermalaw.inventionRheumatologyRandomized controlled trialQuality of lifelawSeverity of illnessmedicineHumansPharmacology (medical)IloprostProspective StudiesDosingInfusions IntravenousProspective cohort studySystemic Sclerosis Raynaud's phenomenon Iloprost Quality of lifeScleroderma SystemicDose-Response Relationship DrugVascular diseasebusiness.industryRaynaud DiseaseMiddle Agedmedicine.diseaseSurgeryTreatment OutcomeAnesthesiaQuality of LifeFemalebusinessIloprostmedicine.drugRheumatology
researchProduct

One-year renal and cardiac effects of bisoprolol versus losartan in recently diagnosed hypertensive patients: a randomized, double-blind study.

2009

BACKGROUND AND OBJECTIVES: Hypertension is a significant cause of chronic renal injury and its effective treatment is capable of reducing the rate of renal failure. beta-Adrenoceptor antagonists (beta-blockers) have been reported to induce a deterioration in renal function, while several data have indicated a renoprotective effect of treatment with the angiotensin II type 1 receptor antagonist losartan. Previous studies of the interaction between the selective beta(1)-blocker bisoprolol and kidney function were performed only for short- and medium-term periods. The aim of this study was to compare the antihypertensive efficacy and renal and cardiac haemodynamic effects of bisoprolol with th…

AdultMalemedicine.medical_specialtyTime Factorsmedicine.drug_classRenal functionHemodynamicsEssential hypertensionKidneyKidney Function TestsLosartanlaw.inventionRandomized controlled trialDouble-Blind MethodlawInternal medicinemedicineBisoprololHumansPharmacology (medical)Antihypertensive Agentshypertension losartanbisiprololbusiness.industryHeartGeneral MedicineMiddle AgedReceptor antagonistmedicine.diseaseAngiotensin IILosartanBisoprololHeart Function TestsHypertensionCardiologyFemalebusinessmedicine.drug
researchProduct

Statin therapy and plasma coenzyme Q10 concentrations—A systematic review and meta-analysis of placebo-controlled trials

2015

Statin therapy may lower plasma coenzyme Q10 (CoQ10) concentrations, but the evidence as to the significance of this effect is unclear. We assessed the impact of statin therapy on plasma CoQ10 concentrations through the meta-analysis of available RCTs. The literature search included selected databases up to April 30, 2015. The meta-analysis was performed using either a fixed-effects or random-effect model according to I(2) statistic. Effect sizes were expressed as weighted mean difference (WMD) and 95% confidence interval (CI). The data from 8 placebo-controlled treatment arms suggested a significant reduction in plasma CoQ10 concentrations following treatment with statins (WMD: -0.44 μmol/…

AdultMalemedicine.medical_specialtyUbiquinoneAtorvastatinPharmacologyPlaceboGastroenterologychemistry.chemical_compoundDouble-Blind MethodInternal medicineHumansMedicineRosuvastatinClinical significanceAgedRandomized Controlled Trials as TopicPharmacologyCoenzyme Q10business.industryMiddle AgedPlacebo EffectConfidence intervalchemistrySimvastatinCase-Control StudiesFemaleHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessPravastatinmedicine.drugPharmacological Research
researchProduct

Treatment of idiopathic oligozoospermia with tamoxifen--a randomized controlled study.

1992

There is no conclusive evidence of the usefulness of tamoxifen in the treatment of idiopathic oligozoospermia (OAT-syndrome), as it has been used mostly in uncontrolled studies. We herein report on the controlled treatment of OAT-syndrome with tamoxifen versus placebo following a randomized design. Seventy-six men with sperm counts of 2-20 x 10(6) ml-1, sperm motility of 20-50%, and sperm morphology (abnormal cells) between 50 and 80% were involved in the study. Patients with varicocele, a history of testicular maldescent or genital inflammation were excluded. Thirty-nine patients received tamoxifen (30 mg daily), 37 patients placebo. There was a statistically significant increase in the me…

AdultMalemedicine.medical_specialtyUrologyEndocrinology Diabetes and MetabolismVaricoceleUrologyPlacebolaw.inventionRandomized controlled triallawStatistical significanceInternal medicinemedicineHumansTestosteroneSperm motilitySperm Countbusiness.industryOligospermiaLuteinizing HormoneAntiestrogenmedicine.diseaseSpermTamoxifenEndocrinologyReproductive MedicineSperm MotilityFollicle Stimulating HormonebusinessTamoxifenmedicine.drugInternational journal of andrology
researchProduct

Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study…

1995

A total of 83 patients with nonorgan-confined bladder cancer with or without lymph node metastases (tumor stages pT3b, pT4a and/or pN1, pN2) was evaluated in November 1993 for relapse-free and overall survival. All patients underwent radical cystectomy between 1987 and 1991, 38 underwent adjuvant polychemotherapy with methotrexate, vinblastine and cisplatin plus doxorubicin (M-VAC) or epirubicin (M-VEC). Of the 83 patients 49 had entered a prospective randomized trial comparing adjuvant to no adjuvant treatment. The protocol was activated in May 1987. Patient recruitment was concluded in December 1990 because an interim analysis of the 49 randomized patients revealed a significant prognosti…

AdultMalemedicine.medical_specialtyUrologymedicine.medical_treatmentUrologyCystectomyVinblastinelaw.inventionCystectomyRandomized controlled triallawAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProspective StudiesSurvival rateAgedEpirubicinCarcinoma Transitional CellUrinary bladderBladder cancerbusiness.industryMiddle AgedInterim analysismedicine.diseaseCombined Modality TherapyVinblastineSurgerySurvival Ratemedicine.anatomical_structureMethotrexateUrinary Bladder NeoplasmsChemotherapy AdjuvantDoxorubicinLymphatic MetastasisFemaleCisplatinbusinessmedicine.drugEpirubicinThe Journal of urology
researchProduct

Advanced Bladder Cancer (Stages pT3b, pT4a, pN1 and pN2): Improved Survival after Radical Cystectomy and 3 Adjuvant Cycles of Chemotherapy. Results o…

1992

A total of 49 bladder cancer patients with tumor stages pT3b, pT4a and/or pelvic lymph node involvement without microscopic or macroscopic evidence of residual tumor was randomized into 2 comparative groups: the chemotherapy group was to receive 3 adjuvant cycles of methotrexate, vinblastine and cisplatin plus doxorubicin (M-VAC) or epirubicin (M-VEC) after radical cystectomy. The control group received no additional treatment. The protocol was activated in May 1987. Patient recruitment was concluded in December 1990 because an interim analysis of the 49 randomized patients revealed a significant prognostic advantage in favor of 26 patients randomized to the chemotherapy group compared to 2…

AdultMalemedicine.medical_specialtyUrologymedicine.medical_treatmentUrologyCystectomyVinblastinelaw.inventionCystectomyRandomized controlled triallawAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProspective StudiesSurvival rateAgedEpirubicinChemotherapyBladder cancerbusiness.industryMiddle AgedInterim analysismedicine.diseaseSurgeryVinblastineSurvival RateMethotrexateUrinary Bladder NeoplasmsChemotherapy AdjuvantFemaleCisplatinbusinessmedicine.drugEpirubicinJournal of Urology
researchProduct

Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial.

2016

AdultMalemedicine.medical_specialtyUrticariaImmunologyTreatment outcomePlacebo-controlled studyMEDLINEDrug ResistanceHistamine AntagonistsOmalizumabOmalizumablaw.invention030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineRandomized controlled trialDouble-Blind MethodlawInternal medicineAnti-Allergic AgentsImmunology and AllergyMedicineHumansbusiness.industryMiddle AgedSymptomatic dermographismTreatment Outcome030228 respiratory systemMulticenter studyFemalebusinessmedicine.drugThe Journal of allergy and clinical immunology
researchProduct

Omalizumab is effective in cold urticaria—results of a randomized placebo-controlled trial

2016

AdultMalemedicine.medical_specialtyUrticariaImmunologyTreatment outcomePlacebo-controlled studyMEDLINEOmalizumabOmalizumabCold urticarialaw.invention030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineDouble-Blind MethodRandomized controlled triallawInternal medicineAnti-Allergic AgentsmedicineHumansImmunology and Allergybusiness.industryMiddle Agedmedicine.diseaseCold TemperatureTreatment Outcome030228 respiratory systemMulticenter studyPhysical therapyFemalebusinessmedicine.drugJournal of Allergy and Clinical Immunology
researchProduct

Comparison of two different labial salivary gland biopsy incision techniques: A randomized clinical trial

2013

Objectives: To compare the reliability of two different labial salivary gland biopsy (LSGB) incision techniques (vertical versus horizontal incision techniques) and to report the related complications and discomfort. Study Design: 163 patients who underwent LSGB were included in this study. Patients were randomly divided as vertical incision group (n=81) and horizontal incision group (n=82). Demographic and clinical information of each patient were recorded. A questionnaire was prepared and applied together with Visual Analog Scale (VAS) on the subjects verbally at the 7th day, postoperatively. Intraoperative, short- term and delayed complications were evaluated. Results: The mean age of pa…

AdultMalemedicine.medical_specialtyVisual analogue scaleBiopsyOdontologíaSalivary Glands Minorlaw.inventionYoung AdultHematomaPostoperative ComplicationsRandomized controlled triallawSurveys and QuestionnairesBiopsymedicineHumansProspective StudiesProspective cohort studyGeneral DentistryAgedBiopsy incisionmedicine.diagnostic_testbusiness.industryReproducibility of ResultsMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludLipSurgeryLabial salivary glandOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgeryResearch-ArticleFemaleOral SurgerybusinessComplicationMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Radiofrequency, high-frequency, and electrocautery treatments vs partial inferior turbinotomy: microscopic and macroscopic effects on nasal mucosa.

2009

Objective To compare the microscopic and macroscopic effects of radiofrequency, high-frequency, and electrocautery therapies with partial inferior turbinotomy in the treatment of nasal obstruction caused by inferior turbinate hypertrophy. Design Nonrandomized controlled trial. Setting Department of Otolaryngology–Head and Neck Surgery, University of Genoa. Patients The study included 80 patients affected by nasal obstruction from hypertrophied inferior turbinates. Interventions Homogeneous patient groups A, B, C, and D underwent radiofrequency, high-frequency, and electrocautery treatments and partial inferior turbinotomy, respectively, to surgically reduce hypertrophied inferior turbinates…

AdultMalemedicine.medical_specialtyVisual analogue scaleMucociliary clearanceMucous membrane of noseTurbinateslaw.inventionMuscle hypertrophyRandomized controlled triallawmedicineElectrocoagulationHumansNoseAgedPain Measurementmedicine.diagnostic_testbusiness.industryTurbinatesGeneral MedicineMiddle AgedRhinomanometrySurgeryNasal Mucosamedicine.anatomical_structureOtorhinolaryngologyMucociliary ClearanceAnesthesiaCatheter AblationSurgeryFemaleRhinomanometryNasal ObstructionbusinessArchives of otolaryngology--headneck surgery
researchProduct